IQGAP1 and hepatocellular carcinoma: Mo reported that IQGAP1 could enhance cell viability and inhibit anoikis by activating the Src/FAK pathway, indicating that it can be a reliable indicator for metastasis and prognosis of hepatocellular carcinoma (HCC) [12].